BPC-157 Capsule
Gut-focused by delivery, with a reputation for general recovery support.
- A daily oral capsule — no needles
- Often chosen for gut and digestive support
- Effects, if they occur, build gradually
BPC-157 is a recovery peptide studied for tissue-repair and gut pathways. Choose a needle-free daily capsule or a targeted injection — clinician-guided care, made simple.
The same single-ingredient BPC-157, two ways to take it. Your clinician confirms what fits.
Gut-focused by delivery, with a reputation for general recovery support.
Simple, targeted recovery support — BPC-157 on its own, no stacking.
Human clinical evidence for BPC-157 is limited, and oral BPC-157 has not been studied in large controlled trials. Prescription required; not everyone is approved.
Steady, not sudden. BPC-157 is recovery support you build over time, not something you feel right after a dose. Effects, if they occur, are expected to be gradual.
Capsule: needle-free and gut-focused by delivery — often chosen when gut and digestive support is the main interest, alongside general recovery.
Injection: simple, targeted recovery support for people who want BPC-157 on its own.
Most BPC-157 research is preclinical and human evidence is still limited, so your clinician sets expectations for your situation.
Recovery is where progress happens. Lifters, runners, weekend athletes — the work only pays off if your body bounces back.
Long shifts count too. Nurse, technician, or anyone in the trades who spends the day on their feet: BPC-157 is a peptide studied for how it may support tendons, ligaments and muscle.
Your clinician builds your plan around your training, your schedule and your health history.
Human safety data on BPC-157 are limited. Reported side effects may include headache, dizziness, nausea, tiredness and changes in appetite. The injection may also cause pain, redness, swelling or itching where you inject. The capsule may cause mild stomach upset. Tell your clinician about anything that persists or worsens.
Prescription required; treatment is subject to your provider’s evaluation and approval. Taxes may apply where required. Product imagery is stylized for marketing and does not reflect actual labeling, strength or size. Compounded products are not approved, nor evaluated for safety, efficacy, or quality, by the FDA. See Important Safety Information for full pricing and promotional terms.
BPC-157 is a 15-amino-acid peptide first found in human gastric juice. A 2025 review of 36 studies found it is being studied for recovery. Research explores how it may support:
Most research so far is in lab and animal studies. Results vary. Your clinician helps you track yours.
Sources: Vasireddi 2025 · Lee & Padgett 2021
The science, simply provides and inspires your access to research for yourself, this is not at all medical advice nor does it imply offerings or expectations of results or treatments from Riovie Operations LLC.
Licensed provider eligibility review
Included if clinically appropriate
Nutrition and lifestyle support for peptide therapy
Refer to the following important safety details for information on intended use, potential side effects and risks, considerations for specific groups, and possible drug interactions linked to the prescription treatments mentioned.
Riovie encourages users to promptly report any side effects or adverse reactions to a licensed healthcare provider and the pharmacy that dispensed the medication. To report suspected reactions to these medications, contact the FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch.
For emergencies, call 911 or go to your nearest emergency department.
All advertisements from riovie.com are paid for by Riovie and are intended to market Riovie’s services. Some advertisements may feature paid actors or dramatizations. When real Riovie customers or endorsements are included, this will be clearly disclosed. Individual results may vary, and specific outcomes are not guaranteed.
Riovie connects users with licensed healthcare providers for evaluations regarding the suitability of the treatments advertised. It may also assist with prescription coordination through an external pharmacy network.
Riovie acts as a managed services provider and does not offer medical advice, fill prescriptions, or function as a licensed healthcare facility or pharmacy. Instead, it provides technology and administrative support to enable medical consultations and prescription logistics. For further details, see Riovie’s Terms of Service.
Occasionally, the website may present promotional pricing or special introductory offers. Pricing may change at any time due to supply or market conditions at the discretion of riovie.com. Introductory or promotional pricing, including “first month” offers, applies only to the plan and product listed at the time of purchase.
Prescription drugs require evaluation and approval by a qualified healthcare provider, and issuance is solely at the provider’s discretion. Access to treatment plans and medications is not assured.
Prescriptions issued through Riovie may be filled by licensed pharmacies within its affiliated network.
All prescription medications involve potential risks. Please review all associated safety details and consult your provider for personalized advice.
In certain situations, healthcare providers may prescribe compounded medications, which are custom-prepared by licensed compounding pharmacies based in the U.S. These medications are not FDA-approved for safety or effectiveness but may be used when alternatives are not available or appropriate.
Riovie helps facilitate compounded medication fulfillment via its partner pharmacy network. These formulations are personalized to meet individual patient requirements and may differ from commercial products.
Riovie is not affiliated with, sponsored by, or endorsed by the manufacturer of any brand-name medication. Any brand names referenced are the property of their respective owners and are used for identification only.
For any questions about Riovie’s services or advertising content, please reach out to support@riovie.com.
Please be aware that compounded drugs are not FDA-approved and do not undergo clinical studies to evaluate for safety and efficacy. Your healthcare provider may prescribe a compounded peptide based on your medical consultation.
BPC-157 is compounded as a single-ingredient product by a state-licensed pharmacy under the U.S. Department of Health and Human Services’ interim enforcement discretion policy for certain peptides (October 2026). That policy is not an FDA approval and may be revised; it covers BPC-157 acetate for the routes listed here only. Human research on BPC-157 is limited, and most published studies are preclinical (laboratory and animal).
The FDA has noted that clinical safety information for the commonly proposed routes of BPC-157 is insufficient.
Do not use BPC-157 if:
Inform your healthcare provider if you:
Serious risks include:
Common side effects: pain, redness, swelling, or itching at the injection site, headache, dizziness, nausea, tiredness, and changes in appetite.
Administration: Inject subcutaneously on the schedule your clinician prescribes, rotating sites in the stomach, thigh, or upper arm. Use only the supplies dispensed with your prescription.
Reporting side effects: Contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Compounded BPC-157 capsules are not FDA-approved but may be prescribed legally based on your provider’s assessment. The capsule contains the same single compounded active ingredient as the injection by a different route; the amount absorbed can differ between routes and between individuals. Oral BPC-157 has not been studied in large controlled trials.
All of the contraindications, precautions and serious risks listed for BPC-157 injection above apply equally to the capsule. Review that section in full before starting.
Inform your healthcare provider if you also:
Common side effects: headache, dizziness, tiredness, and mild stomach upset such as nausea, bloating, or changes in bowel habits.
Administration: Swallow capsules whole on the schedule your clinician prescribes. Do not open, crush, or chew them unless instructed.
Reporting side effects: Contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
This document is not comprehensive. Always speak with a licensed healthcare provider for personalized medical advice.